TicoVac

Pfizer Laboratories Div Pfizer Inc🇺🇸 United States

FDA Page

Effective Date: Mar 17, 2026
Approval ID: da102644-62a9-41c2-8a91-6fc19a03e6f1
Products: 2 registered
Version: 7

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TICOVAC safely and effectively. See full prescribing information for TICOVAC. TICOVAC (Tick-Borne Encephalitis Vaccine), Suspension for intramuscular injectionInitial U.S. Approval: 2021

Quick Stats

Total Products2

Labelers1

Label Sections16

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.